Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...demic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
more
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
HIV Country Intelligence - HIV Country Profiles
One key aim of tuberculosis (TB) prevention and care is to render them more people-centred, which means further boosting and improving ambulatory care models across the countries of Eastern Europe and central Asia. This note is intended to remind interested parties of the evidence that shows that am...bulatory care is both feasible and safe
more
Vinay P. Saldanha( UNAIDS Regional Director- Eastern Europe & Central Asia)
Session 1 Wednesday 30/01/2019
30-31 January 2019, Bucharest
Accessed: 29.09.2019
Quizás le hayan dicho recientemente que tiene la enfermedad de la TB.
Puede que se sienta algo confundido; esto es normal. Usted está recibiendo
mucha información nueva. Es posible que le sirva leer este folleto y enterarse
de lo que dicen algunas personas como usted sobre la TB
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
The 2022 edition of the report is as usual, based primarily on data gathered by WHO from national ministries of health in annual rounds of data collection. In 2022, 202 countries and territories with more than 99% of the world’s population and TB cases reported data
more